Lee-may Chen
University of California, San Francisco · 218 works · 7,008 citations · h-index 41
Top works
- Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer
- Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy
- Gynecologic Cancer as a “Sentinel Cancer” for Women With Hereditary Nonpolyposis Colorectal Cancer Syndrome
- Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
- Pathologic features of endometrial carcinoma associated with HNPCC
- Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions
- An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations
- NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
- S ociety of G ynecologic O ncology recommendations for the prevention of ovarian cancer
- A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2 -Mutated Ovarian Carcinoma or Other Solid Tumors
- NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
- Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA Mutation Carriers
- Characteristics of success in mentoring and research productivity — A case–control study of academic centers
- Influence of Gynecologic Oncologists on the Survival of Patients With Endometrial Cancer
- Enhanced Recovery Pathways for Improving Outcomes After Minimally Invasive Gynecologic Oncology Surgery
- Splenectomy and Surgical Cytoreduction for Ovarian Cancer
- Multistep Level Sections to Detect Occult Fallopian Tube Carcinoma in Risk-reducing Salpingo-oophorectomies From Women With BRCA Mutations
- NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.
- Early Detection of High-grade Tubal Serous Carcinoma in Women at Low Risk for Hereditary Breast and Ovarian Cancer Syndrome by Systematic Examination of Fallopian Tubes Incidentally Removed During Benign Surgery
- Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non–clinic‐based sample of women in northern California